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Abstract
Background: The prevalence of childhood obesity has increased rapidly during the last three decades in the
Netherlands. It is assumed that mainly environmental factors have contributed to this trend. Parental overweight
and low social economic status are risk factors for childhood obesity. Childhood obesity affects self-esteem and has
negative consequences on cognitive and social development. Obese children tend to become obese adults, which
increases the risk for developing cardiovascular complications, type 2 diabetes mellitus, and psychosocial problems.
Additionally, the secretion of several gastrointestinal hormones, responsible for appetite and food intake, is
impaired in obese subjects. Weight reduction through lifestyle changes in order to change health risks is, until
now, suggested as the preferred treatment for childhood obesity.
The objective of this study is the effect evaluation of a family-based cognitive behavioral multidisciplinary lifestyle
treatment. The intervention aims to establish long-term weight reduction and stabilization, reduction of obesity-
related health consequences and improvement of self-image by change of lifestyle and learning cognitive
behavioral techniques.
Study design/Methods: In this randomized clinical trial newly presented children with obesity (8-17 years old) are
divided, by randomization, in an intervention and control group, both consisting of 40 obese children. The
intervention is carried out in groups of 8-11 children, and consists of respectively 7 and 5 separate group meetings
for the children and their parents and 1 joint group meeting of 2 ½ hours. Main topics are education on nutrition,
self-control techniques, social skills, physical activity and improvement of self-esteem. The control group is given
advice on physical activity and nutrition. For normal data comparison, data were collected of 40 normal-weight
children, 8-17 years old.
Discussion: Because of the increasing prevalence of childhood obesity and the impact on the individual as well as
on society, prevention and treatment of obesity in children is of great importance. For evaluation of short- and
long-term effects of the treatment, measurements are taken before and after 3 months of treatment, and after 12
and 24 months follow-up. During these visits clinical and biochemical data are determined, cardiovascular fitness
tests are performed and quality of life questionnaires are completed.
Trial registration: International Standard Randomised Controlled Trial Number Register ISRCTN36146436
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During the last three decades the prevalence of childhood
obesity has increased dramatically in western countries,
including the Netherlands [1-7]. In the Netherlands the
highest prevalence of obesity is found in children and
adolescents of Turkish and Moroccan origin [8,9]. Other
risk factors for developing obesity include parental over-
weight or obesity, low socio-economic status, and low
parental education level [4,9-11].
The adult cut-off values of BMI for overweight and
obesity are 25 and 30 kg/m
2, respectively, and are related
to increased risk for morbidity and mortality [1]. How-
ever, in children BMI is age and gender dependent, so
that BMI is usually expressed as standard deviation score
(SDS). The working group on childhood obesity of the
International Obesity Task Force (IOTF) determined cut-
off lines for overweight and obesity in children based on
the BMI-SDS that ended at 25 and 30 kg/m
2, respec-
tively, at 18 years of age, obtained from 6 large growth
studies carried out before the obesity epidemic [2].
The rapidly increasing prevalence of childhood obesity
seen during the last few decades, is mostly the result of
an increased food consumption and a change from a
more physically active lifestyle to a more sedentary one.
Studies indicate that 50% of the children and 80% of the
adolescents with obesity will remain obese in their adult
life [12-14]. In adults obesity is associated with a higher
risk for developing type 2 diabetes mellitus and cardio-
vascular disease [15-19] and in children obesity is asso-
ciated with increased prevalence of hypertension,
dyslipidemia and impaired glucose metabolism [20-27].
The clustering of these risk factors is called the Metabolic
Syndrome (MS) also known as Syndrome X or the Insu-
lin Resistance Syndrome [28].
For adults various definitions of the MS have been
described. The most commonly used definitions are
those proposed by the World Health Organization [29],
the National Cholesterol Education Program’sA d u l t
Treatment Panel III [30] and the International Diabetes
Federation [31]. These three definitions concur for the
essential components (central obesity, hypertension,
impaired HDL-cholesterol (HDL), triglycerides (TG) and
impaired glucose tolerance). For the pediatric age group
several definitions have been proposed, but modifications
of the three mentioned definitions for adults are used
most often [32-38]. However, consensus on the cut-off
levels of the components of the MS for pediatric patients
is even more difficult to obtain than for adult patients.
One of the reasons may be that in children these cut-off
levels are not only influenced by gender and ethnicity,
but also by age and pubertal stage. In order to get better
insight in the impact of the MS in the pediatric age
group an internationally accepted definition is necessary.
Moreover, it has become clear that the adipose tissue
is an endocrine organ [39,40]. It does not just serve as a
fat deposit but it secretes a wide range of hormones and
other proteins. Obesity represents a chronic state of
inflammation, with increased levels of the C-reactive
protein (CRP) [41-43] and decreased levels of adiponec-
tin [44-47]. This chronic state of inflammation may be
the common soil for the development of insulin resis-
tance and cardiovascular disease. It has been shown that
obese subjects, both adults and children, have signifi-
cantly lower levels of adiponectin compared to normal
weight individuals [44-49]. After clinically relevant
weight loss, levels of adiponectin increase accompanied
by improvement of insulin sensitivity [48,50].
The insulin secretion after consumption of nutrients is
regulated by neural and hormonal signals from the gut
and the intestine [51,52]. The gastrointestinal tract is the
largest endocrine organ responsible for the regulation
and signalling response of food intake to the brain
[51,52]. Gastrointestinal hormones are the key mediators
in these processes of food intake regulation. Several gas-
trointestinal hormones are impaired in obese persons,
including ghrelin [51-56], peptide YY (PYY) [51,52,57-59]
and glucagon-like peptide 1 (GLP-1) [52,60-64]. In con-
trast to many other endocrine hormones, gut hormones
have predominantly short-term actions [52].
Ghrelin is a 28 amino acid peptide released from X/A-
like cells of the gastric oxyntic glands, and in lower
amounts from the small intestine and the hypothalamus
[51-53]. Ghrelin is the only gut hormone known to
increase food intake. An inverse association is found
between circulating levels of ghrelin and BMI, so that
obese subjects have lower levels of ghrelin [51-54,65-67].
There is still much uncertainty about the effect of weight
loss on the ghrelin response. Some studies found
increased ghrelin levels after weight lost [51,52,56], but
others could not confirm this finding [56,68].
Both PYY and GLP-1 are synthesised and released after
food intake by L-cells of the distal gut [51,52,57,59,69]. For
fasting PYY an inverse association is found with BMI, in
both adults [51,52] and children [51,52,57,59], whereas no
significant association with body weight was found for
fasting GLP-1 [52]. Postprandial levels of both hormones
[51,52,59,52,60-64,70] are found to be blunted in obese
individuals, and weight loss seems to affect this [59,52,
61,71]. However, the mechanisms underlying the synthesis
and release of especially GLP-1 from L-cells are largely
unknown.
Besides these physiological changes, obesity also has a
huge impact on the psychosocial well-being of the child
with obesity [7,72-75]. Obesity is often associated with
feeling ugly, lazy, stupid and with low self-control,
which results in a negative self-image and, consequently,
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can aggravate the obesity because the child can use eat-
ing as a coping strategy [72,76].
The question which intervention is most effective in
treating both the physiological and psychological aspects
of childhood obesity has not yet been definitely answered.
The recently published update of the Cochrane review
‘Interventions for treating obesity in children’ [77]
included 54 randomized clinical trials on lifestyle inter-
ventions, with 36 focusing on (family-based) behaviorally
orientated treatment programs. From the 54 included
studies on lifestyle interventions, 40 interventions lasted
longer than 6 months, 6 of which up to one year and 4
lasting 2 years. The aim of this Cochrane review was to
ascertain which intervention is most effective in the treat-
ment of childhood obesity. However, study design, dura-
tion of follow up and outcome measures differed
significantly in the included studies and it was only possi-
ble to give a recommendation. The results of the meta-
analysis showed that for the treatment of childhood obe-
sity a behavioral lifestyle intervention, combined with
parental involvement, is preferred over standard care or
self-help.
The intensity of the intervention appears important for
the efficacy, because an observational study, including
129 treatment centers in Germany, Austria and Switzer-
land [78] demonstrated a significantly positive association
between BMI-SDS reduction and intensity of the inter-
vention after 24 months follow-up, while there was no
association with duration. These authors also found a
reduced BMI-SDS in nearly half of the children after 24
months of follow-up, with 25% of them showing a reduc-
tion of > 0.5 SDS, which has been demonstrated to be
clinically relevant [79-81]. Younger children (< 12 years)
showed significantly higher success rates at 24 months’
follow-up.
A major problem with lifestyle intervention programs is
the high percentage of incomplete follow-up data due to
drop-out or lack of documentation, which makes it very
difficult to reliably assess the effectiveness of the treat-
ment. Therefore, in order to accomplish long-term weight
loss and health improvement, future research should focus
on adequately powered long-term (> 6 months) evaluation
of lifestyle interventions, with psychosocial determinants
for behavioral change and parental involvement.
Objective
The primary aim of this study is the effect evaluation of
a family-based multidisciplinary cognitive behavioral
treatment on obesity (expressed as body mass index
(BMI)-standard deviation score (SDS)) compared to
standard care (advice on increased physical activity and
dietary changes) in children with obesity. The secondary
aim of the study is to investigate the effect of this
treatment on changes in waist circumference, insulin
sensitivity, inflammation, secretion of gastrointestinal
hormones and changes in physical fitness and quality of
life, compared to standard care. Furthermore, we aim at
assessing the effects of possible predictive factors for the
long-term response to treatment.
Main research question
1. Do children (8-17 yr.) with obesity show a significant
decrease (> 0.5) in BMI-SDS (as defined by Cole et al.
[82]) after 3 months of intensive treatment compared to
children who were given advice on increased physical
activity and dietary changes?
Secondary research questions
1. Do children with obesity have significantly more bene-
ficial effect of 3 months intensive treatment compared to
standard care on changes in waist circumference, insulin
sensitivity, secretion of gastrointestinal hormones, cardio-
vascular fitness and quality of life?
2. Will the hypothesized beneficial effects of 3 months
intensive treatment in children with obesity persist after
12 and 24 months of follow-up?
3. Are ethnic background of the children, the level of
parental education, or the socio-economic status predic-
tive variables for the degree of obesity in these children,
and for the success of treatment?
Methods/Design
Design
The study design is a randomized clinical trial for 2
years.
Newly presented children with obesity referred to the
pediatrician are physically examined. If a child meets the
inclusion criteria of the study, the pediatrician informs
the parents and the child about the study. After written
informed consent, the children are randomized to the
intervention and control group, after stratification for
gender and ethnicity, in two age groups, one from 8 to 12
years and one from 13 to 17 years. An experienced assis-
tant blinded for the study design measures weight and
height.
Ethnicity is determined according to self-reports by
the parents. For this analysis children are classified as
‘Northern European’ if both parents report the Northern
European ethnicity, and ‘Others’ if one or both parents
report another ethnicity.
To enable comparison of the participants’ anthropo-
metric and biochemical data with proper reference data,
an age-matched sample of healthy children with normal
weight is recruited from the youth health services (Jeugd
GGD Haaglanden).
Measurements are taken before (t = 0 months) and
after (t = 3 months) the treatment of the intervention
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long-term purposes the intervention group is also evalu-
ated after 24 months. The control group is offered the
same treatment regimen after 12 months.
The normal weight control group is measured once.
Eligibility criteria
Children with obesity (according to Cole et al. [2]) aged
8-17 years, living in the Hague and in the area around
the Hague and referred to a pediatrician, are invited to
participate. Reasons for referral are overweight or obesity,
and increased risk of co-morbidity (e.g. hypertension,
family history of diabetes mellitus and/or hypercholester-
olemia and/or cardiovascular disease before the age of
55, Hindustani ethnicity).
Potential participants are excluded if their knowledge
of the Dutch language, intelligence or social skills are
insufficient to participate in the group. Other exclusion
criteria are use of medication that might have an effect
on weight loss, medical co-morbidities that could affect
participation, or previous enrollment in another cognitive
behavioral treatment program with the focus on reducing
obesity.
Recruitment
During the first pediatric consultation inclusion and
exclusion criteria are checked. Motivation and expecta-
tions of both children and parents are evaluated; e.g. it is
checked whether they understand the reason to partici-
pate and know why it is important to reduce body
weight, and whether their expectations of the treatment
are realistic. Pros and cons of treatment versus no treat-
ment are discussed, as well as alternative treatment
options. If the children do not fulfill the inclusion or
exclusion criteria an alternative treatment is offered to
the parents and the child.
Randomization
For the children who meet the inclusion criteria the par-
ents and the children are asked to sign the informed con-
sent. Following informed consent of all participating
children and parents the children are stratified by gender
and ethnicity (‘North European’ and ‘Other’) and rando-
mized to the intervention or control group according to
coin-tossing. In order to obtain a similar size of the inter-
vention and control groups, blocked randomization is
applied with an allocation ratio of 1:1. Randomization is
carried out by a member of the team who does not take
part in the treatment. Both the intervention and control
groups consist of 40 children per group. The children in
the intervention group are divided into smaller groups of
10, depending on the child’s age. After randomization,
children receive a randomization code. All data are ana-
lyzed according to this randomization code. The key to
the source data is only known by the researcher and
research coordinator. The researcher is familiar with the
study procedure, is trained prior to the study and collects
all data for this study. The normal-weight control group
consists of 40 children, 8-17 years, with normal body
weight.
Ethic Aspects
This study is conducted in agreement with the ‘Declara-
tion of Helsinki’.
Approval is obtained from the regional medical ethical
committee Zuid-West Holland. All parents and children
gave their written informed consent.
Treatment
Treatment Intervention group
The cognitive behavioral treatment program consists of
an intensive phase of three months, followed by booster
sessions for a total period of two years. During the
intensive phase of the program the intervention group is
offered 7 group meetings of 2½ hour and the parents
are offered 5 separate parent meetings and 1 meeting
together with the children.
The primary goal of the cognitive behavioral treatment
is recognition and acknowledgement of the obesity and
learning a healthy lifestyle. This is accomplished by
health education and by teaching cognitive behavioral
techniques.
The secondary goals of the treatment program are a
reduction of 10% of the body weight during the inten-
sive phase of the treatment and a further reduction or
at least maintenance of the reduced body weight.
A treatment period of at least two years is chosen
because it will take time to adapt to a new lifestyle and
the risk of relapse is considerable.
Screening phase During the screening phase the chil-
dren with their parents are seen at two separate occa-
sions individually by a dietitian, a child-physiotherapist,
a child-psychologist and a social worker. In this way it is
evaluated whether the timing of the treatment is appro-
priate, and whether there are individual family situations
which could interfere with the treatment. Also causal
factors of the obesity are discussed and opportunities to
establish lifestyle changes are mapped out.
Dietitian During the first consultation the weight and
diet history of the child and their family are verified.
Also their general knowledge of nutrition and their
expectations of the role of a dietitian in helping them to
reduce body weight are discussed. At the end of the ses-
s i o nt h ec h i l di sa s k e dt om a k ead i e tr e p o r to ft w o
weekdays and one weekend day. During the second ses-
sion an evaluation of the diet reports is made and infor-
mation is provided about nutrition and healthy eating
behavior according to the traffic light nutritional list.
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eral main food groups (e.g. fruits, vegetables, grains,
milk and other dairy products, meat, fish, and others).
Foods within each group are color coded according to
the calorie density per average serving and Dutch stan-
dards for health nutrition. The colors, similarly to those
of a traffic light, are green for “go”, orange for “approach
with caution”,a n dr e df o r“stop”. The goal of the use of
the traffic light nutritional list is not only to reduce cal-
orie intake but more importantly to learn healthy eating
behavior. At the end of the second session achievable
treatment goals are formulated.
Physiotherapist Current physical activity level and
sedentary behavior of the child is reviewed. Energy
intake versus energy expenditure is evaluated and visua-
lized for the child by a computer program. With this
computer program the child can choose a favorite pro-
duct from a nutritional list and the program then shows
the child the amount of time and intensity of physical
activity that is necessary to burn the energy consumed.
Also options to change or optimize physical and seden-
tary activities are debated. The child is advised how to
find suitable exercise programs.
Psychologist Most children with obesity do not have
sufficient insight in how obesity develops and how to
reduce body weight. The role of the child psychologist
is to help the child not only to reduce weight by learn-
ing cognitive behavioral techniques, but also to deal
with and accept their own body.
For the success of the treatment the children must be
motivated and able to change behavior. It is explained
that the role of the parents during the treatment is that
of ‘the therapeutic helper’. The degree of suffering with
regards to body image and the role of eating and obesity
in the family are evaluated as well.
During the individual consultations by the child psy-
chologist several questionnaires are asked to be filled;
the ‘Dutch Eating Behavior Questionnaire’ (Nederlandse
Vragenlijst Eetgedrag/ NVE) [84], the ‘Child Behavioral
Checklist’ (CBCL) [85], the ‘Youth Self Report’ (YSR)
[85], the ‘Teacher Report Form’ (TRF) [85] and the ‘Per-
ceived Competence Scale for Children’ (CompetentieBe-
levenisSchaal voor Kinderen/ CBSK) [86].
Before the child starts with the group sessions indivi-
dual treatment goals are written down in a contract. It
is important that the goals are achievable to avoid disap-
pointment. Also a buddy is chosen by the child who will
help to achieve his or her goals.
Treatment Group treatment is a useful way to learn
cognitive behavioral techniques especially if groups are
limited to 8-10 participants. Children can learn from
each other (modeling). Peer group support is especially
important for the older children group (≥ 12 yrs).
Before the first group session the children receive a
treatment manual with the objectives and goals of the
treatment and, per session, information about the topics
discussed. To achieve successful treatment results it is
important, at the beginning of the treatment, to focus
more on the effort to change habits and the input of the
participants and less on the weight reduction goals. This
is accomplished by making the child aware of its own
actions and way of living that has led to his or her
obesity.
Several cognitive behavioral techniques are learned
(knowledge, skills and attitude) during the intensive
phase of the treatment in order to maintain long-term
lifestyle change and body weight reduction. The cogni-
tive behavioral strategies are learned during six sessions
of 2½ hours per session. Sessions are given biweekly.
Each session contains the following components:
￿ Determination of body weight
￿ Homework discussion and evaluation
￿ Education
￿ Physical activity
￿ Role playing
￿ Discussing homework for next meeting
￿ Set goals linked to educational topics of the session
Parental Involvement Not only the motivation to
change the lifestyle of the children is important, but also
the motivation of the parents. Parents must be willing
to invest time in the treatment. Separate parallel parent
group sessions (5 evenings) are offered by a dietitian
and a social worker. In most cases parents do the shop-
ping and food preparation, so for the treatment to be
successful parental involvement and support is essential.
The role of parents is that of ‘the therapeutic helper’
who gives positive feedback to their children and sup-
ports the child in a positive way.
Parents should be a role model for their children, giv-
ing a good example through eating healthy food,
increasing physical activity and decreasing sedentary
activity.
Children’s Group Sessions
Educational topics in session 1 Most children with
obesity have negative experiences with group activities.
For example, they are often not included in social events
or chosen last by peers during sport activities. There-
fore, during the first session much time is spent in get-
ting acquainted with each other. A good group bond is
important for the effect of the treatment because peer
support can be very helpful in the treatment of obese
children. During this part of the session children give
their individual motivation for participating.
The topic of the second part of this session is nutri-
tional information and the balance between energy
intake and energy expendit u r e .T h i si se x p l a i n e db y
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misbalance are discussed. When the energy intake part
of the balance is greater than the energy expenditure
part, energy expenditure must be increased or energy
intake must be decreased, or both.
Educational topics in session 2 The main topic of the
second session of the treatment phase is again informa-
tion on healthy nutrition. Different categories of nutri-
tion and quantities of each category linked to a healthy
eating pattern are discussed. Children learn how to read
product labels and to obtain information on misleading
advertisement. They also discuss how to deal with meals
(breakfast, lunch, diner, 2 healthy snacks), and how to
make healthy choices and develop healthy eating habits
(small bits, slow eating, eating at the family table, no
other activities during eating). In games the educational
topics are rehearsed and participants need to label pro-
ducts according to the traffic light method [83].
Educational topics in session 3 In this session self-con-
trol techniques to cope with difficult situations are
taught. Children formulate and acknowledge difficult
situations (e.g. birthday parties, holidays, lunch breaks at
school, being at home alone). Problem solving alterna-
tives are debated (e.g. to avoid a situation, doing some-
thing else, participate in a situation and eat less, or
participate followed by extra exercise afterwards). The
problem-solving alternatives are rehearsed with role-
playing.
Other psycho-educational topics reviewed during the
third session are self-reward (when coping well with a
difficult situation) and self-regulation situations (making
a plan how to integrate healthy behavior in daily living).
Stimulus control is also one of the psycho-educational
topics of the third session (remove unhealthy stimuli at
home, encourage healthy behavior, eat at the dinner
table, reduction of environmental stimuli linked to
eating)
Educational topics in session 4 Most people associate
obesity with being ugly, lazy or stupid which makes chil-
dren with obesity often the subject of teasing by peers.
The topics of the fourth session are therefore coping with
teasing and being teased, how to deal with it and how to
react with dignity. The children are explained that there
are three coping strategies to deal with this situation; react
angry (fight), walk away (flight) or deal with the situation
(preferred strategy). Using role-playing the children are
taught to react with a dignified, but powerful response.
During this session the children are asked to think of
someone in their environment who can help them during
difficult situations or when they are teased.
Educational topics in session 5 The focus of the fifth
session is self-image. Most children with obesity have a
low self-image and a low health-related quality of life.
Not only other people associate obesity with being ugly,
lazy or stupid, but the children also think likewise about
themselves. It is difficult for them to mention positive
things about themselves. Children are taught to take a
positive look at themselves and name positive, nice
things or characteristics about themselves and other
children in the group.
Educational topics in session 6 During the sixth ses-
sion the children are given the opportunity to repeat
topics discussed during the other sessions. Also cogni-
tive strategies and relapse techniques are taught to
maintain newly learned behavior.
Parent Group Sessions
Session 1 Parents are given information on the treat-
ment program of the children and what they can expect
of their own group sessions. Information on healthy
nutrition, product information, quantities, eating
moments, eating locations, how to help their children
(also when there are childreni nt h ef a m i l yw i t han o r -
mal body weight) are discussed. Parents also receive
advice on parenting styles to give strict rules but also
manage the family in a pleasant way.
Session 2 During the second session parents are taught
how to support their children during the treatment and
thereafter by acknowledging the child’s efforts and giving
positive feedback. It is made clear to the parents that for
the treatment to be a success, parental support is very
important.
Session 3 Parenting styles are taught during the third
session on how to set boundaries and how to limit the
sometimes abnormal eating behavior of their child.
Session 4 During this session topics of the previous ses-
sions are repeated, and questions relevant to the obesity
subject are answered.
Session 5 During the last separate parental group ses-
sion a therapist discusses the role of all other family
members with regard to the treatment in the family (e.g.
are other family members supportive, how do they cope
with the lifestyle changes?).
Joint Session During the last session children and parents
celebrate the end of the intensive period in a healthy way.
Children are asked to make healthy snacks and in this way
the children can bring into practice how to cope with a
normally difficult situation. Games and activities are
planned as well, so children and parents can bring into
practice that festive parties can also be associated with fun
and social interaction instead of the intake of food alone.
Follow-up Booster sessions are a very important com-
ponent of the treatment of children with obesity. In
order to maintain the newly learned behavior booster
sessions are necessary during the first two years. The
child psychologist and the social worker organize the
booster sessions. The topics that are repeated are: pro-
blem solving techniques and relapse prevention
techniques.
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The control group is given an initial physical activity
and nutritional advice. After 12 months the children are
offered the multidisciplinary treatment. During the 12
months study period the children are seen at start, after
3 months and at the end of the period just before they
start the treatment.
Study procedures
Medical examination
During the first visit to the pediatric clinic general infor-
mation is collected concerning pregnancy (duration of
gestation, smoking, hyperemesis, pre-eclampsy, medica-
tion, diabetes) and birth (position of the child during deliv-
ery, complications during delivery, birth weight, height,
head circumference). Also information on motor and
mental development (current educational level) of the
child is collected. Furthermore, information on the highest
accomplished educational degree and current work of the
parents, as well as height, weight and activity level of the
parents and other family members and the occurrence of
diseases in the family is collected.
At physical examination the occurrence of hirsutism,
acanthosis nigricans and possible dysmorphic characteris-
tics is evaluated. Pubertal development is recorded by the
pediatrician according to Tanner [87]. Breast development
in girls and genital development in boys is used for puber-
tal classification into two groups. Boys with genital stage 1
and girls with breast stage 1 are classified as prepubertal,
and boys and girls with stage 2-5 are classified as pubertal.
Anthropometric parameters
Weight is measured to the nearest of 0.1 kg using an
electronic scale (SECA 911, Vogel & Halke, Hamburg,
Germany) and height to the nearest of 0.1 cm with a sta-
diometer (Holtain, limited, Crymych, Dyfed, Britain) in
underwear and barefoot. The BMI is calculated as weight
/ height squared (kg/m
2). Subjects are classified as obese
using BMI gender- and age specific international cut-off
levels developed by Cole et al. [2] BMI expressed as stan-
dard deviation score (SDS) for Dutch reference data [82]
is used as the main outcome parameter.
Waist circumference (WC, in cm) is measured with an
anthropometric tape midway between the lower rib
margin and the iliac crest at the end of gentle expira-
tion. The waist to height ratio (WC/Ht) is calculated as
WC/height, both measured in centimeters.
Blood pressure measurements (Criton Dinamap, No.
8100) are performed in a relaxed sitting position, in
duplicate; the last measurement is used for analyses.
Blood sample analysis
With the participant in the supine position, blood sam-
ples are taken by venipuncture after an overnight fast.
Before blood sampling, the fasting state is verbally con-
firmed by the participant and the parent. Fasting blood
samples are taken to determine glucose, insulin,
C-peptide, total cholesterol, HDL-cholesterol, LDL-
cholesterol, triglycerides, free fatty acids, free T4, TSH
and inflammation parameters (CRP, adiponectin).
Mixed Meal Tolerance Test
The children are asked to consume at least an amount
of 150 g of carbohydrates three days prior to the mixed
meal tolerance test and continue with their normal daily
physical activities. The day before the test the children
are asked not to consume any food or drinks after
10 pm, with the exception of tap water.
On the morning of the mixed meal tolerance test the
fasting state is verbally confirmed by the participant and
the parents. An antecubital intravenous catheter is
placed for blood sampling. Fasting blood samples are
taken twice with an interval of 15 minutes (t = -15 and
t = 0). After the second fasting blood sample is taken,
the participant receives a mixed meal bolus of 200 mL
(Nutridrink Yoghurt Style, Nutricia, Zoetermeer, The
Netherlands). The mixed meal bolus consists of 49%
carbohydrates, 35% lipids and 16% proteins. After the
consumption of the mixed meal bolus, blood samples
are taken two times with 15 minutes intervals (t = 15
and t = 30) and four times with 30 minutes interval (t-
60, t = 90, t = 120 and t = 150). Blood samples are ana-
lyzed and plasma glucose, plasma insulin and gut hor-
mones (Ghrelin, GLP-1, PYY) are determined. In order
to be able to analyze levels of the gut hormones GLP-1
a n dP Y Yi ti sn e c e s s a r yt oa d dt h ee n z y m ed i p e p t i d y l
peptidase IV (DPPIV) to the tubes.
Insulin Resistance and Insulin Sensitivity
An index for insulin resistance is calculated according to
the Homeostasis Assessment Model for insulin resis-
tance (HOMA-IR) formula: (fasting insulin (mU/mL) ×
fasting glucose (mmol/L)) / 22.5 [88].
Insulin sensitivity is calculated using the quantitative
insulin-sensitivity check index (QUICKI) formula: 1/(log
fasting insulin (mU/L)+log fasting glucose (mg/dl)) [89].
Voluntary Maximal Exercise Test
T h ep h y s i c a lf i t n e s so ft h ec h i l d r e ni sd e t e r m i n e db ya
voluntary maximum exercise test on a treadmill using
breath-by-breath analysis and plots according to Was-
serman [90].
The exercise test consists of three stages; a reference
stage (2 minutes rest measurement prior to the exercise
test), the test stage (the exercise test till voluntary
exhaustion) and a recovery stage (2 minutes recovery
measurement in rest after the exercise test). The test
stage starts with a velocity of 4 km/h and an angle of
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Page 7 of 120% during 1 minute. Every minute the velocity is
increased with 0.5 km/h and the angle with 2%, till
voluntary exhaustion. During the test the participants
are encouraged to exert a maximum effort. At the end
of the test the children are asked to grade the level of
exhaustion by using the Borg scale [91] and the reason
to stop.
In adults a maximum effort is achieved when two of
the following criteria are fulfilled:
￿ The difference in heart rate between the last two
stages was less than 5 beats per minute.
￿ T h ed i f f e r e n c ei nV O 2 w a sl e s st h a n1 0 0m L / m i n
between the last two stages.
￿ A Respiratory Exchange Ratio (RER) of > 1.0.
However, the first two criteria are not always found in
adults and rarely in children. Therefore, in this study
peak values are referred to instead of maximum values.
Peak values are reached when the children look physi-
cally exhausted and a RER of > 1.0 is accomplished. The
physical fitness is calculated from the absolute peak
value of oxygen uptake, standardized to age and gender
(VO2peak-SDS). Yet the absolute peak oxygen uptake in
obese can give an overestimation of the real physical fit-
ness because of their increased body size [90]. For that
reason also the peak oxygen uptake adjusted for body
weight, age and gender (VO2peak-SDS-kg) is determined
to establish a more realistic value for the physical
fitness.
Health Related Quality of Life
The health related Quality of Life (HRQOL) of the chil-
dren is determined by the questionnaires DISABKIDS
and KIDSCREEN [92]. The DISABKIDS and KIDSC-
REEN projects developed an instrument with a generic
part (KIDSCREEN), and a chronic generic part (DISAB-
K I D S ) .T h eK I D S C R E E Np a r to ft h eq u e s t i o n n a i r ei s
suitable for children aged between 8-18 years, and the
DISABKIDS part for children aged between 4-18 years.
The generic part of the questionnaire is used to com-
pare children with a disease with healthy children. For
this part only the child version is used. With respect to
DISABKIDS, also the parental version is used, to com-
pare the HRQOL reported by the child with the child’s
HRQOL from the parents’ view.
The KIDSCREEN contains 52 questions divided over
10 subscales of 3-7 items each. The DISABKIDS part of
the questionnaire contains 37 questions divided over 6
subscales of 6-7 items each. Every question can be
answered by choosing from 5 options: never, almost
never/ seldom, average/ sometimes, quite often, always.
The items are scored on a 5-point scale (0-4). Both
parts are scored by summing the responses for the 52
and 37 items, respectively, after adjustment for the nega-
tive items, and expressed as percentages between 0-100.
A higher score reflects a better HRQOL.
KIDSCREEN is used to compare the HRQOL of the
children with obesity with a normal weight control
group and DISABKIDS to compare the obese children
in the intervention group with the children in the obese
control group. The KIDSCREEN questionnaire has
demonstrated a Cronbach a reliability coefficient ranging
between .77 and .89 for all ten domains [92]. The Cron-
bach a reliability coefficient of the child version of the
DISABKIDS ranges between .70 to.87 for children aged
8-12 years and between .77 to.90 for children aged 13-
16 years [92]. A Cronbach a ≥0 . 7i sc o n s i d e r e da sg o o d
validity.
Other questionnaires used during the screening phase of
the treatment
￿ Dutch Eating Behavior Questionnaire (Nederlandse
Vragenlijst Eetgedrag/ NVE):
The NVE [84] is administered during the screening
phase. It consists of three subscales: Emotional Eat-
ing (13 items), External Eating (10 items), and
Restrained Eating (10 items). The items are scored
on a 3-point Likert-type scale ranging from never to
very often. The items in the conditional format also
have the response option not relevant.Ah i g hs c o r e
reflects a specific eating behavior of the particular
subscale.
The NVE scales have been proven to provide good
internal consistency, satisfactory factorial validity
and dimensional stability [72,84].
To assess the child’s psychological and social adjust-
ment three versions of the Child Behavior Checklist are
asked to fill in. One version is filled in by the parents
(Child Behavior Checklist), one by the child themselves
(Youth Self Report) and one by a school teacher (Teacher
Report Form):
￿ Child Behavior Checklist (CBCL):
The Dutch version of the CBCL [85] is completed
during the screening phase by the parents. The
questionnaire includes 138 items and yields scores
for total behavior problems, internalizing and exter-
nalizing behavior of their child. Also three scores for
competence are determined (activity, social compe-
tence, school competence)
￿ Youth Self Report (YSR):
The children fill in the YSR [85] version of the
CBCL during the screening phase to visualize the
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externalizing behavior.
￿ Teacher Report Form (TRF):
A school teacher of the child fills in the TRF [85]
version of the CBCL in order to determine the inter-
nalizing and externalizing behavior of the child at
school.
￿ Perceived Competence Scale for Children (Competen-
tie Belevings Schaal voor Kinderen/ CBSK):
The CBSK [86] is used during the screening phase to
determine the self-perception or self-concept of the
child. The CBSC consists of 28 items and assesses
the child’s self-perception in four different areas of
perceived competence; cognitive ability, physical
activity, peer relations, and general self-esteem.
Type of Analysis
The analyses are performed by using the Statistical
Package for Social Science SPSS, v. 17.0 for WINDOWS;
SPSS Inc., Chicago, IL, USA) and the level of signifi-
cance is set to < 0.05, according to an intention-to-treat
analysis.
Data are checked for normality before analysis using
descriptive statistics and histograms. Data are expressed
as mean ± standard deviation (continuous variables) and
as count and percentage (categorical variables), unless
specified otherwise.
For the analysis of treatment effect between both
obese study groups for continuous data, independent t-
tests, (M)AN(C)OVA and mixed model for repeated
measures are used per time point, adjusted for baseline
values. Categorical data are analyzed with the Chi-
square test for comparison between groups. In addition,
paired t-tests, (M)AN(C)OVA and mixed model for
repeated measures are used to compare the parameters
within treatment groups over time. For predictive analy-
sis linear and logistic regression analysis is used for con-
tinuous dependent variables and binomial variables,
respectively.
Power Calculation
The sample size of a study was based on the power cal-
culation for unpaired means with normal distribution
and can be calculated by the following formula:
N1 =N 2 =( z 1−β +z 1−α/2)2 × ((σ2
1 + σ2
2/(μ1 − μ2)2)
In this study a = 0.05 and b = 0.20 is chosen, so z1-a/2 =
1.96 en z1-b =0 . 8 4 .
The results of an unpublished pilot study of the pro-
posed treatment given to children with obesity in our
hospital showed a clinically relevant difference of 0.6
BMI-SDS between intervention and control group, and
the difference between post-treatment and baseline ran-
ged between -2.85 and + 0.70. The difference between
the means is therefore chosen as μ1 - μ2 =0 . 6a n dt h e
estimated sigma, under normality assumption, will be
3.55/4 = 0.89, so s1
2 + s2
2 = 1.58.
In the formula this determines a N1 =N 2 = 35. Consid-
ering the likely phenomenon of drop-out a N1 =N 2 =4 0
is chosen. The sample size is not adjusted for stratification.
Burden and risks
For evaluation of short-term, midterm and long-term
effects of the treatment, measurements are taken at the
beginning of the treatment, after 3 months treatment and
after 12 (intervention- and control group) and 24 (inter-
vention group only) months of follow-up. During these
three (four) visits a physical examination is performed,
cardiovascular fitness measured, a mixed meal test per-
formed and blood samples are taken. Children are also
asked to complete a quality of life questionnaire.
Discussion
The increasing prevalence of childhood obesity and its
impact on individuals and society requires effective pre-
ventive programs and therapeutic strategies. The study
‘Haagse Maatjes’: an effect evaluation of a family-based
cognitive behavioral multidisciplinary lifestyle intervention,
is a randomized controlled trial with a longitudinal design.
The study aims to establish long-term weight reduction
and stabilization, reduction of obesity related health conse-
quences and improvement of the self-image by a change in
lifestyle. In order to adjust to a healthy lifestyle, thinking
patterns, level of physical activity and eating behavior of
the child with obesity and their family must change. For
long term-effect of the treatment it is also important that
coping strategies and social skills are taught to children
with obesity to deal with low self esteem, low self-control
and to teach social skills. Also parental involvement and
support are necessary for long-lasting, successful treat-
ment results.
We hypothesize that after the intensive treatment per-
iod the intervention group will show a significantly lower
B M I - S D Sc o m p a r e dt ob a s e l i n ea n dt h ec o n t r o lg r o u p ,
and that in subjects with a BMI-SDS decrease of more
than 0.5, which is considered a clinically relevant weight
reduction [79,81,93], a significant health improvement
(secondary study outcomes) is attained.
The design of the study is prospective with follow-up
measurements at 3, 12 and 24 months. The longitudinal
design of the study makes it possible to perform a predic-
tive analysis, rather than only cross-sectional correlations.
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Page 9 of 12Furthermore, as mentioned by the authors of the
Cochrane review [77], there is an urgent need for inter-
ventions with a psychosocial focus for behavioral change
and good clinician-family interaction. We believe that
with our study design we do focus on these important
aspects.
The children in the intervention group are followed for 2
years and those in the control group for 1 year. Children in
the control group are offered the treatment after 1 year,
since it is preferable to start treatment of obesity as soon as
possible. We expect that some children will drop out of the
study during or after the treatment phase. In our power
calculation a 10% loss to follow-up was accounted for.
The strength of our study is that, next to the evalua-
tion of the changes in BMI-SDS after intensive lifestyle
treatment in obese children, we also assess the effect of
weight loss on metabolic health status, inflammation,
physical fitness, health-related quality of life and secre-
tion of some gastrointestinal hormones.
The results of this study will provide more insight in
the long-term effects of a family-based cognitive beha-
vioral multidisciplinary intervention on weight and BMI-
SDS, as well as intended health improvement in children
with obesity and their family.
Abbreviations
BMI: Body Mass Index; BMI-SDS: Body Mass Index Standard Deviation Score;
CBCL: Child Behavior Checklist; CBSK: Perceived Competence Scale for
Children (CompetentieBelevingsSchaal voor Kinderen); CRP: C-Reactive
Protein; GLP-1: Glucagon-like peptide 1; HDL-cholesterol: High Density
Lipoprotein Cholesterol; HOMA-IR: Homeostasis Assessment Model for Insulin
Resistance; HRQOL: Health related Quality of Life; MS: Metabolic Syndrome;
NVE: Dutch Eating Behavior Questionnaire (Nederlandse Vragenlijst
Eetgedrag); PYY: Peptide YY; QUICKI: quantitative insulin-sensitivity check
index; RER: Respiratory Exchange Ratio; TG: Triglyceride; TRF: Teacher Report
Form; VO2peak-SDS = Peak oxygen uptake; adjusted for gender and age;
VO2peakSDS-kg = Peak oxygen uptake; adjusted for gender age and body
weight; WC: Waist Circumference; WC/Ht: Waist to Height Ratio; YSR: Youth
Self Report
Acknowledgements
The study was partly funded by an unrestricted educational grant by Pfizer
and an unrestricted educational grant by a non-profit foundation (de
Stichting Vrienden van het JKZ). This research was carried out at the
Department of Pediatrics, Juliana Children’s Hospital (Haga Hospital), The
Hague, the Netherlands.
We thank all members of the multidisciplinary team, especially Esther Smit-
Hijkoop (dietitian), Alexandra Hotke (child physiotherapist) and Eric Sterenberg
(social worker) for their time and patience in treating the children and the
participating children and their family. We thank Nutricia BV, Zoetermeer, The
Netherlands, for supplying specialized drinks for the mixed meal tests.
Author details
1Department of Pediatrics, Juliana Children’s Hospital/ HagaHospital, the
Hague, The Netherlands.
2Department of Pediatrics, Leiden University
Medical Center, Leiden, The Netherlands.
3Department of Endocrinology and
Metabolism, Leiden University Medical Center, Leiden, The Netherlands.
4Psycho-medical Health Centre de Jutters, the Hague, The Netherlands.
Authors’ contributions
All authors are responsible for the design of the study and contributed to
the intellectual content of the protocol. RCV was responsible for the
implementation of the intervention, data collection, data analysis and
drafted the study protocol with suggestions and contribution of all other
authors. ECAMH obtained financial support. All authors read and approved
the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 20 August 2010 Accepted: 6 May 2011 Published: 6 May 2011
References
1. Obesity: preventing and managing the global epidemic: Report of a WHO
consultation. World Health Organ Tech Rep Ser 2000, 894:i-253.
2. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH: Establishing a standard
definition for child overweight and obesity worldwide: international
survey. BMJ 2000, 320:1240-1243.
3. Ebbeling CB, Pawlak DB, Ludwig DS: Childhood obesity: public-health
crisis, common sense cure. Lancet 2002, 360:473-482.
4. Fredriks AM, Van Buuren S, Wit JM, Verloove-Vanhorick SP: Body index
measurements in 1996-7 compared with 1980. Arch Dis Child 2000,
82:107-112.
5. Hirasing RA, Fredriks AM, Van Buuren S, Verloove-Vanhorick SP, Wit JM:
[Increased prevalence of overweight and obesity in Dutch children,
and the detection of overweight and obesity using international
criteria and new reference diagrams]. Ned Tijdschr Geneeskd 2001,
145:1303-1308.
6. Reilly JJ: Descriptive epidemiology and health consequences of
childhood obesity. Best Pract Res Clin Endocrinol Metab 2005, 19:327-341.
7. Renders CM, Seidell JC, van Mechelen W, Hirasing RA: [Overweight and
obesity in children and adolescents and preventative measures]. Ned
Tijdschr Geneeskd 2004, 148:2066-2070.
8. de Vries SI, Bakker I, van Overbeek K, Boer ND, Harris TB, Hopman-Rock M:
kinderen in prioriteitwijken: lichamelijke (in)activiteit en overgewicht Leiden:
TNO kwaliteit van Leven; 2005.
9. Fredriks AM, Van Buuren S, Sing RA, Wit JM, Verloove-Vanhorick SP:
Alarming prevalences of overweight and obesity for children of Turkish,
Moroccan and Dutch origin in The Netherlands according to
international standards. Acta Paediatr 2005, 94:496-498.
10. Nagel G, Wabitsch M, Galm C, Berg S, Brandstetter S, Fritz M, et al:
Determinants of obesity in the Ulm Research on Metabolism, Exercise
and Lifestyle in Children (URMEL-ICE). Eur J Pediatr 2009.
11. Shrewsbury V, Wardle J: Socioeconomic status and adiposity in
childhood: a systematic review of cross-sectional studies 1990-2005.
Obesity (Silver Spring) 2008, 16:275-284.
12. Guo SS, Roche AF, Chumlea WC, Gardner JD, Siervogel RM: The predictive
value of childhood body mass index values for overweight at age 35 y.
Am J Clin Nutr 1994, 59:810-819.
13. Mossberg HO: 40-year follow-up of overweight children. Lancet 1989,
2:491-493.
14. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH: Long-term morbidity
and mortality of overweight adolescents. A follow-up of the Harvard
Growth Study of 1922 to 1935. N Engl J Med 1992, 327:1350-1355.
15. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005,
365:1415-1428.
16. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Definition of
metabolic syndrome: Report of the National Heart, Lung, and Blood
Institute/American Heart Association conference on scientific issues
related to definition. Circulation 2004, 109:433-438.
17. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al:
Cardiovascular morbidity and mortality associated with the metabolic
syndrome. Diabetes Care 2001, 24:683-689.
18. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E,
Tuomilehto J, et al: The metabolic syndrome and total and cardiovascular
disease mortality in middle-aged men. JAMA 2002, 288:2709-2716.
19. Reaven GM: Banting lecture 1988. Role of insulin resistance in human
disease. Diabetes 1988, 37:1595-1607.
20. Bao W, Srinivasan SR, Berenson GS: Persistent elevation of plasma insulin
levels is associated with increased cardiovascular risk in children and
young adults. The Bogalusa Heart Study. Circulation 1996, 93:54-59.
21. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE,
Wattigney WA: Association between multiple cardiovascular risk factors
Vos et al. Trials 2011, 12:110
http://www.trialsjournal.com/content/12/1/110
Page 10 of 12and atherosclerosis in children and young adults. The Bogalusa Heart
Study. N Engl J Med 1998, 338:1650-1656.
22. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS: The relation of
overweight to cardiovascular risk factors among children and
adolescents: the Bogalusa Heart Study. Pediatrics 1999, 103:1175-1182.
23. Li X, Li S, Ulusoy E, Chen W, Srinivasan SR, Berenson GS: Childhood
adiposity as a predictor of cardiac mass in adulthood: the Bogalusa
Heart Study. Circulation 2004, 110:3488-3492.
24. Magnussen CG, Venn A, Thomson R, Juonala M, Srinivasan SR, Viikari JS,
et al: The association of pediatric low- and high-density lipoprotein
cholesterol dyslipidemia classifications and change in dyslipidemia
status with carotid intima-media thickness in adulthood evidence from
the cardiovascular risk in Young Finns study, the Bogalusa Heart study,
and the CDAH (Childhood Determinants of Adult Health) study. JA m
Coll Cardiol 2009, 53:860-869.
25. Reinehr T, Wunsch R: Relationships between cardiovascular risk profile,
ultrasonographic measurement of intra-abdominal adipose tissue, and
waist circumference in obese children. Clin Nutr 2009.
26. Ruiz JR, Rizzo NS, Ortega FB, Loit HM, Veidebaum T, Sjostrom M: Markers of
insulin resistance are associated with fatness and fitness in school-aged
children: the European Youth Heart Study. Diabetologia 2007,
50:1401-1408.
27. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, et al:
Prevalence of impaired glucose tolerance among children and
adolescents with marked obesity. N Engl J Med 2002, 346:802-810.
28. Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome.
Nature 2006, 444:881-887.
29. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes
mellitus and its complications. Part 1: diagnosis and classification of
diabetes mellitus provisional report of a WHO consultation. Diabet Med
1998, 15:539-553.
30. Executive Summary of The Third Report of The National Cholesterol
Education Program (NCEP) Expert Panel on Detection, Evaluation, And
Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel
III). JAMA 2001, 285:2486-2497.
31. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome–a new worldwide
definition. Lancet 2005, 366:1059-1062.
32. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH: Prevalence of a
metabolic syndrome phenotype in adolescents: findings from the third
National Health and Nutrition Examination Survey, 1988-1994. Arch
Pediatr Adolesc Med 2003, 157:821-827.
33. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI: The
metabolic syndrome in overweight Hispanic youth and the role of
insulin sensitivity. J Clin Endocrinol Metab 2004, 89:108-113.
34. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N:
Prevalence of the metabolic syndrome in American adolescents:
findings from the Third National Health and Nutrition Examination
Survey. Circulation 2004, 110:2494-2497.
35. Ford ES, Ajani UA, Mokdad AH: The metabolic syndrome and
concentrations of C-reactive protein among U.S. youth. Diabetes Care
2005, 28:878-881.
36. Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P: Prevalence of the
insulin resistance syndrome in obesity. Arch Dis Child 2005, 90:10-14.
37. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al:
Obesity and the metabolic syndrome in children and adolescents. N Engl
J Med 2004, 350:2362-2374.
38. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al: The
metabolic syndrome in children and adolescents - an IDF consensus
report. Pediatr Diabetes 2007, 8:299-306.
39. Ahima RS: Adipose tissue as an endocrine organ. Obesity (Silver Spring)
2006, 14(Suppl 5):242S-249S.
40. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin
Endocrinol Metab 2004, 89:2548-2556.
41. Alvarez JA, Higgins PB, Oster RA, Fernandez JR, Darnell BE, Gower BA:
Fasting and postprandial markers of inflammation in lean and
overweight children. Am J Clin Nutr 2009, 89:1138-1144.
42. Balagopal P, George D, Patton N, Yarandi H, Roberts WL, Bayne E, et al:
Lifestyle-only intervention attenuates the inflammatory state associated
with obesity: a randomized controlled study in adolescents. J Pediatr
2005, 146:342-348.
43. Reinehr T, Stoffel-Wagner B, Roth CL, Andler W: High-sensitive C-reactive
protein, tumor necrosis factor alpha, and cardiovascular risk factors
before and after weight loss in obese children. Metabolism 2005,
54:1155-1161.
44. Bacha F, Saad R, Gungor N, Arslanian SA: Adiponectin in youth:
relationship to visceral adiposity, insulin sensitivity, and beta-cell
function. Diabetes Care 2004, 27:547-552.
45. Martin LJ, Woo JG, Daniels SR, Goodman E, Dolan LM: The relationships of
adiponectin with insulin and lipids are strengthened with increasing
adiposity. J Clin Endocrinol Metab 2005, 90:4255-4259.
46. Nemet D, Wang P, Funahashi T, Matsuzawa Y, Tanaka S, Engelman L, et al:
Adipocytokines, body composition, and fitness in children. Pediatr Res
2003, 53:148-152.
47. Reinehr T, Roth C, Menke T, Andler W: Adiponectin before and after
weight loss in obese children. J Clin Endocrinol Metab 2004, 89:3790-3794.
48. Fischer-Posovszky P, Wabitsch M, Hochberg Z: Endocrinology of adipose
tissue - an update. Horm Metab Res 2007, 39:314-321.
49. Ruiz JR, Ortega FB, Warnberg J, Sjostrom M: Associations of low-grade
inflammation with physical activity, fitness and fatness in prepubertal
children; the European Youth Heart Study. Int J Obes (Lond) 2007,
31:1545-1551.
50. Reinehr T, Stoffel-Wagner B, Roth CL: Adipocyte fatty acid-binding protein
in obese children before and after weight loss. Metabolism 2007,
56:1735-1741.
51. Karra E, Batterham RL: The role of gut hormones in the regulation of
body weight and energy homeostasis. Mol Cell Endocrinol 2009.
52. Neary MT, Batterham RL: Gut hormones: Implications for the treatment of
obesity. Pharmacol Ther 2009.
53. Bacha F, Arslanian SA: Ghrelin suppression in overweight children: a
manifestation of insulin resistance? J Clin Endocrinol Metab 2005,
90:2725-2730.
54. Bellone S, Rapa A, Vivenza D, Castellino N, Petri A, Bellone J, et al:
Circulating ghrelin levels as function of gender, pubertal status and
adiposity in childhood. J Endocrinol Invest 2002, 25:RC13-RC15.
55. Leidy HJ, Gardner JK, Frye BR, Snook ML, Schuchert MK, Richard EL, et al:
Circulating ghrelin is sensitive to changes in body weight during a diet
and exercise program in normal-weight young women. J Clin Endocrinol
Metab 2004, 89:2659-2664.
56. Reinehr T, Roth CL, Alexy U, Kersting M, Kiess W, Andler W: Ghrelin levels
before and after reduction of overweight due to a low-fat high-
carbohydrate diet in obese children and adolescents. Int J Obes (Lond)
2005, 29:362-368.
57. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, et al:
Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J
Med 2003, 349:941-948.
58. Le Roux CW, Batterham RL, Aylwin SJ, Patterson M, Borg CM, Wynne KJ,
et al: Attenuated peptide YY release in obese subjects is associated with
reduced satiety. Endocrinology 2006, 147:3-8.
59. Roth CL, Enriori PJ, Harz K, Woelfle J, Cowley MA, Reinehr T: Peptide YY is a
regulator of energy homeostasis in obese children before and after
weight loss. J Clin Endocrinol Metab 2005, 90:6386-6391.
60. Adam TC, Westerterp-Plantenga MS: Glucagon-like peptide-1 release and
satiety after a nutrient challenge in normal-weight and obese subjects.
Br J Nutr 2005, 93:845-851.
61. Adam TC, Jocken J, Westerterp-Plantenga MS: Decreased glucagon-like
peptide 1 release after weight loss in overweight/obese subjects. Obes
Res 2005, 13:710-716.
62. Ranganath LR, Beety JM, Morgan LM, Wright JW, Howland R, Marks V:
Attenuated GLP-1 secretion in obesity: cause or consequence? Gut 1996,
38:916-919.
63. Tomasik PJ, Sztefko K, Malek A: GLP-1 as a satiety factor in children with
eating disorders. Horm Metab Res 2002, 34:77-80.
64. Tomasik PJ, Sztefko K, Starzyk J: Cholecystokinin, glucose dependent
insulinotropic peptide and glucagon-like peptide 1 secretion in children
with anorexia nervosa and simple obesity. J Pediatr Endocrinol Metab
2004, 17:1623-1631.
65. Ikezaki A, Hosoda H, Ito K, Iwama S, Miura N, Matsuoka H, et al: Fasting
plasma ghrelin levels are negatively correlated with insulin resistance
and PAI-1, but not with leptin, in obese children and adolescents.
Diabetes 2002, 51:3408-3411.
Vos et al. Trials 2011, 12:110
http://www.trialsjournal.com/content/12/1/110
Page 11 of 1266. Romon M, Gomila S, Hincker P, Soudan B, Dallongeville J: Influence of
weight loss on plasma ghrelin responses to high-fat and high-
carbohydrate test meals in obese women. J Clin Endocrinol Metab 2006,
91:1034-1041.
67. Soriano-Guillen L, Barrios V, Martos G, Chowen JA, Campos-Barros A,
Argente J: Effect of oral glucose administration on ghrelin levels in
obese children. Eur J Endocrinol 2004, 151:119-121.
68. Carnier J, Lofrano MC, Prado WL, Caranti DA, de PA, Tock L, et al: Hormonal
alteration in obese adolescents with eating disorder: effects of
multidisciplinary therapy. Horm Res 2008, 70:79-84.
69. Stock S, Leichner P, Wong AC, Ghatei MA, Kieffer TJ, Bloom SR, et al:
Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and
hunger responses to a mixed meal in anorexic, obese, and control
female adolescents. J Clin Endocrinol Metab 2005, 90:2161-2168.
70. Rask E, Olsson T, Soderberg S, Johnson O, Seckl J, Holst JJ, et al: Impaired
incretin response after a mixed meal is associated with insulin
resistance in nondiabetic men. Diabetes Care 2001, 24:1640-1645.
71. Reinehr T, de Sousa G, Roth CL: Fasting glucagon-like peptide-1 and its
relation to insulin in obese children before and after weight loss.
J Pediatr Gastroenterol Nutr 2007, 44:608-612.
72. Breat C, van Winckel MAJM: Behandelingsstrategieen bij kinderen met
overgewicht Houten: Bohn Stafleu van Loghum; 2009.
73. Dietz WH: Health consequences of obesity in youth: childhood
predictors of adult disease. Pediatrics 1998, 101:518-525.
74. Nowicka P: Dietitians and exercise professionals in a childhood obesity
treatment team. Acta Paediatr Suppl 2005, 94:23-29.
75. Wardle J, Cooke L: The impact of obesity on psychological well-being.
Best Pract Res Clin Endocrinol Metab 2005, 19:421-440.
76. Bosch J, Daansen P, Breat C: Cognitieve gedragstherapie bij obesitas,
praktijkreeks gedrachtherapie deel 19 Houten: Bohn Stafleu van Loghum;
2001.
77. Oude Luttikhuis H, Baur L, Jansen H, Shrewsbury VA, O’Malley C, Stolk RP,
et al: Interventions for treating obesity in children. Cochrane Database
Syst Rev 2009, CD001872.
78. Reinehr T, Widhalm K, l’Allemand D, Wiegand S, Wabitsch M, Holl RW: Two-
year follow-up in 21,784 overweight children and adolescents with
lifestyle intervention. Obesity (Silver Spring) 2009, 17:1196-1199.
79. Reinehr T, Kiess W, Kapellen T, Andler W: Insulin sensitivity among obese
children and adolescents, according to degree of weight loss. Pediatrics
2004, 114:1569-1573.
80. Reinehr T, de Sousa G, Toschke AM, Andler W: Long-term follow-up of
cardiovascular disease risk factors in children after an obesity
intervention. Am J Clin Nutr 2006, 84:490-496.
81. Wunsch R, de Sousa G, Toschke AM, Reinehr T: Intima-media thickness in
obese children before and after weight loss. Pediatrics 2006,
118:2334-2340.
82. Cole TJ, Roede MJ: Centiles of body mass index for Dutch children aged
0-20 years in 1980–a baseline to assess recent trends in obesity. Ann
Hum Biol 1999, 26:303-308.
83. Epstein LH, Wing RR, Valoski A: Childhood obesity. Pediatr Clin North Am
1985, 32:363-379.
84. Strien Tv, Frijters JER, Bergers GPA, Defares PB: The Dutch Eating Behavior
Questionnaire (DEBQ) for assessment of restrained, emotional and
external eating behavior. International Journal of Eating Disorders 1986,
5:295-315.
85. Achenbach SA, Edelbrock C: Manual for the Child Behavior Checklist and
Profile Burlington: University of Vermond, Department of Psychiatry; 1991.
86. Veerman JW, Straathof MAE, Treffers BRH, van den Bergh BRH, ten Brink LT:
The Self-Perception Profile for Children (Dutch version) Lisse: Swets &
Zeitlinger; 2007.
87. Tanner J: Growth at Adolescence: with a general consideration of the effects
of hereditary and enviromental factors upon growth and maturation from
birth to maturity. 2 edition. Oxford: Blackwell Scientific Publications; 1962.
88. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC:
Homeostasis model assessment: insulin resistance and beta-cell function
from fasting plasma glucose and insulin concentrations in man.
Diabetologia 1985, 28:412-419.
89. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al:
Quantitative insulin sensitivity check index: a simple, accurate method
for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000,
85:2402-2410.
90. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ: Principles of
exercise testing and interpretation. 4 edition. Philiadelphia, PA, USA:
Lippincott Williams & Wilkins; 2005.
91. Borg G: Psychophysical scaling with applications in physical work and
the perception of exertion. Scand J Work Environ Health 1990, 16(Suppl
1):55-58.
92. Ravens-Sieberer U, Schmidt S, Gosch A, Erhart M, Petersen C, Bullinger M:
Measuring subjective health in children and adolescents: results of the
European KIDSCREEN/DISABKIDS Project. Psychosoc Med 2007, 4:Doc08.
93. Reinehr T, Kersting M, Alexy U, Andler W: Long-term follow-up of
overweight children: after training, after a single consultation session,
and without treatment. J Pediatr Gastroenterol Nutr 2003, 37:72-74.
doi:10.1186/1745-6215-12-110
Cite this article as: Vos et al.: The effect of family-based
multidisciplinary cognitive behavioral treatment in children with
obesity: study protocol for a randomized controlled trial. Trials 2011
12:110.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Vos et al. Trials 2011, 12:110
http://www.trialsjournal.com/content/12/1/110
Page 12 of 12